Pionyr
is a California-based biotechnology company that discovers and develops immunotherapies for the treatment of cancer... Read morePionyr
is a California-based biotechnology company that discovers and develops immunotherapies for the treatment of cancer... Read more
President & CEO
Steven P. James
News
Aug 26, 2023
Global Legal Chronicle
Pionyr: Ikena Oncology's Acquisition of Pionyr Immunotherapeutics
Aug 07, 2023
BioPharma Dive
Pionyr: Ikena acquires cancer startup Pionyr after Gilead passes on buyout
Aug 07, 2023
Benzinga
Pionyr: Ikena Oncology Acquires Pionyr Immunotherapeutics: Analysts See The Deal As Positive Move
Aug 07, 2023
Endpoints News
Pionyr: Ikena Oncology inks $43M cash grab in all-stock deal for Pionyr
May 25, 2023
Business Wire
Press Release: Pionyr : Pionyr Immunotherapeutics' Phase 1a Study of TREM1-targeting Antibody PY159 for the Treatment of Solid Tumors Featured at ASCO 2023
Mar 23, 2023
Endpoints News
Pionyr: Gilead passes on fully acquiring Pionyr, as eyes now turn to Tizona, a fellow summer 2020 buyout option
Mar 23, 2023
BioSpace
Pionyr: Pionyr Immunotherapeutics and Gilead Change Exclusive Option Agreement
Mar 23, 2023
Seeking Alpha
Pionyr: Gilead waives rights to acquire immune-oncology biotech Pionyr
Nov 07, 2022
FirstWord Pharma
Pionyr: Pionyr Immunotherapeutics' MARCO-targeting Antibody Program, PY265, for Treatment of Solid Tumors Featured at SITC 2022
Sep 21, 2022
Clinical Trials Arena
Pionyr: Pionyr doses first subject in Phase Ib cancer antibody trial
Pionyr Competitors
1
2
3
4
5
6
7
8
9
10